327 related articles for article (PubMed ID: 32178612)
1. An Analysis of QSAR Research Based on Machine Learning Concepts.
Keyvanpour MR; Shirzad MB
Curr Drug Discov Technol; 2021; 18(1):17-30. PubMed ID: 32178612
[TBL] [Abstract][Full Text] [Related]
2. Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR.
Tropsha A; Isayev O; Varnek A; Schneider G; Cherkasov A
Nat Rev Drug Discov; 2024 Feb; 23(2):141-155. PubMed ID: 38066301
[TBL] [Abstract][Full Text] [Related]
3. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
5. Insights into Machine Learning-based Approaches for Virtual Screening in Drug Discovery: Existing Strategies and Streamlining Through FP-CADD.
Hussain W; Rasool N; Khan YD
Curr Drug Discov Technol; 2021; 18(4):463-472. PubMed ID: 32767944
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Machine-Learning-Based Chemoinformatics: A Comprehensive Review.
Niazi SK; Mariam Z
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511247
[TBL] [Abstract][Full Text] [Related]
7. Applications of Quantitative Structure-Activity Relationships (QSAR) based Virtual Screening in Drug Design: A Review.
Achary PGR
Mini Rev Med Chem; 2020; 20(14):1375-1388. PubMed ID: 32348219
[TBL] [Abstract][Full Text] [Related]
8. 4D- quantitative structure-activity relationship modeling: making a comeback.
Fourches D; Ash J
Expert Opin Drug Discov; 2019 Dec; 14(12):1227-1235. PubMed ID: 31513441
[No Abstract] [Full Text] [Related]
9. Machine Learning and Computational Chemistry for the Endocannabinoid System.
Atz K; Guba W; Grether U; Schneider G
Methods Mol Biol; 2023; 2576():477-493. PubMed ID: 36152211
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive ensemble in QSAR prediction for drug discovery.
Kwon S; Bae H; Jo J; Yoon S
BMC Bioinformatics; 2019 Oct; 20(1):521. PubMed ID: 31655545
[TBL] [Abstract][Full Text] [Related]
11. 5-Year Trends in QSAR and its Machine Learning Methods.
Devinyak OT; Lesyk RB
Curr Comput Aided Drug Des; 2016; 12(4):265-271. PubMed ID: 27156868
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Applied to the Modeling of Pharmacological and ADMET Endpoints.
Göller AH; Kuhnke L; Ter Laak A; Meier K; Hillisch A
Methods Mol Biol; 2022; 2390():61-101. PubMed ID: 34731464
[TBL] [Abstract][Full Text] [Related]
13. Machine learning and traditional QSAR modeling methods: a case study of known PXR activators.
Neal WM; Pandey P; Khan SI; Khan IA; Chittiboyina AG
J Biomol Struct Dyn; 2024; 42(2):903-917. PubMed ID: 37059719
[TBL] [Abstract][Full Text] [Related]
14. Multi-task learning models for predicting active compounds.
Zhao Z; Qin J; Gou Z; Zhang Y; Yang Y
J Biomed Inform; 2020 Aug; 108():103484. PubMed ID: 32615159
[TBL] [Abstract][Full Text] [Related]
15. Machine learning approaches and their applications in drug discovery and design.
Priya S; Tripathi G; Singh DB; Jain P; Kumar A
Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
[TBL] [Abstract][Full Text] [Related]
16. Development of Predictive QSAR Models of 4-Thiazolidinones Antitrypanosomal Activity Using Modern Machine Learning Algorithms.
Kryshchyshyn A; Devinyak O; Kaminskyy D; Grellier P; Lesyk R
Mol Inform; 2018 May; 37(5):e1700078. PubMed ID: 29134756
[TBL] [Abstract][Full Text] [Related]
17. Deep Neural Networks for QSAR.
Xu Y
Methods Mol Biol; 2022; 2390():233-260. PubMed ID: 34731472
[TBL] [Abstract][Full Text] [Related]
18. Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction.
Liu X; Feng H; Wu J; Xia K
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33837771
[TBL] [Abstract][Full Text] [Related]
19. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
